semaglutide and naltrexone + Naltrexone: Safety & Clinical Evidence – PlexusDx GLP-1s linked to lower rates

Introduction: Why Proper Injection Technique Matters Semaglutide is all the rage right now, and for good reason it works

March 9, 2026 - Spring 2026 Provider Check Up Newsletter is now available

In another Phase 3 clinical trial , participants with obesity or overweight who combined a once-weekly injection of 2.4 mg of semaglutide with a reduced-calorie diet and regular exercise lost an average of 15% of their weight over the study, which lasted 68 weeks (or 1.3 years)

doi: 10.1038/sj.ejcn.1602594

Researchers from Alliance Medical, a European imaging service provider, reviewed oncologic FDG PET-CT scans in patients taking GLP-1 drugs